You told your doctor about the anxiety, the insomnia, the crying spells that come out of nowhere, the overwhelming feeling that you can’t cope the way you used to. And the response was a prescription pad. An SSRI. Maybe it was Lexapro, or Zoloft, or Wellbutrin.

To be clear: this article is not anti-medication. Antidepressants are effective, evidence-based treatments for depression and anxiety disorders, and they help millions of people. But when mood symptoms are driven by hormonal fluctuations during perimenopause, an antidepressant may not be addressing the root cause, and it may not be the most effective option.

The Overprescription Problem

Research has consistently documented that antidepressants are overprescribed to peri- and post-menopausal women. This pattern reflects a broader issue in women’s healthcare: when providers lack specific training in menopause medicine, they default to the tools they know best.

Only 6.8% of OB/GYN residency programs include a menopause medicine curriculum, according to ACOG and related research. Many primary care physicians received even less training. When a woman in her 40s presents with new-onset anxiety and mood changes, insomnia, and emotional reactivity, a provider without menopause-specific knowledge may diagnose depression or generalized anxiety disorder and prescribe accordingly.

The problem isn’t that antidepressants are bad. The problem is that they’re being prescribed without a conversation about whether hormonal changes might be the underlying driver, and whether hormone therapy (HRT) might be more appropriate.

Survey research from NAMS finds that approximately 85% of women experience bothersome symptoms during perimenopause, yet only about 15% report receiving effective treatment. A significant portion of that gap comes from mood symptoms being treated as psychiatric conditions without considering the hormonal context.

How Hormonal Changes Drive Mood Symptoms

During perimenopause, estrogen doesn’t just decline. It fluctuates unpredictably. These fluctuations directly affect the neurotransmitters that regulate mood:

  • Serotonin: Estrogen supports serotonin synthesis and receptor sensitivity. When estrogen drops, serotonin availability decreases, contributing to low mood, anxiety, and irritability.
  • GABA: Progesterone metabolizes into allopregnanolone, which enhances GABA, your brain’s calming neurotransmitter. Declining progesterone reduces this calming effect.
  • Norepinephrine: Estrogen fluctuations destabilize norepinephrine regulation, contributing to hot flashes, anxiety, and the fight-or-flight feelings many women describe.

When mood symptoms emerge because of these hormonal shifts, an SSRI can partially compensate by boosting serotonin availability. But it doesn’t address the progesterone decline, the norepinephrine instability, or the hormonal fluctuations themselves. It treats one downstream effect while leaving the upstream cause untouched.

When Hormone Therapy May Be More Appropriate

For many women whose mood symptoms are driven by the hormonal changes of perimenopause, hormone therapy can be more effective than antidepressants because it addresses the root cause. The 2022 NAMS position statement acknowledges estrogen therapy as a treatment option for mood symptoms during the menopausal transition.

HRT may be a better first-line option when:

  • Mood symptoms are new. If you’ve never had significant depression or anxiety before and these symptoms appeared in your 40s alongside other perimenopause symptoms, hormonal fluctuations are a likely driver.
  • Symptoms are cyclical. If your mood worsens at certain points in your menstrual cycle, that suggests a hormonal component.
  • Other perimenopause symptoms are present. If you’re also experiencing hot flashes, night sweats, sleep disruption, joint pain, or vaginal dryness, HRT can address the mood symptoms and the physical symptoms simultaneously.
  • Standard antidepressant response is incomplete. If you’ve tried an SSRI and it helped partially but you still don’t feel like yourself, the remaining symptoms may be hormonal.

When SSRIs Are the Right Choice

This is not an either-or situation. There are clear scenarios where antidepressants are the appropriate treatment, even in the context of perimenopause:

Pre-existing depression or anxiety

If you have a history of depression or anxiety that predates perimenopause, the hormonal transition may be worsening an existing condition. In this case, continued or adjusted antidepressant therapy, potentially in combination with HRT, may be the best approach.

Contraindications to HRT

For some women, hormone therapy is not recommended due to personal or family history of certain breast cancers, blood clotting disorders, uncontrolled hypertension, or other medical conditions. In these cases, SSRIs and other non-hormonal treatment options can help manage mood symptoms and are even FDA-approved for hot flash management in women who cannot take estrogen.

Personal preference

Some women prefer not to use hormone therapy. That is a valid choice, and antidepressants can be part of an effective treatment plan.

Persistent symptoms despite HRT

If mood symptoms persist after adequate hormone treatment, adding an antidepressant may provide additional benefit. Perimenopause can unmask or trigger genuine depression that requires treatment beyond hormone stabilization.

How to Have the Conversation

If your provider suggests an antidepressant and you want to explore whether hormonal treatment might be more appropriate, here are specific things you can say:

“I’m open to medication if it’s the right fit. Before we start an antidepressant, can we discuss whether my mood symptoms might be related to perimenopause? I’ve never experienced depression or anxiety like this before, and it started around the same time as other changes I’m noticing.”

“I know hormone therapy can address mood symptoms during perimenopause. Am I a candidate for that? Can we discuss the risks and benefits compared to an SSRI?”

“Could we try HRT first for my mood symptoms and reassess in 2 to 3 months? If my mood doesn’t improve, I’m willing to consider an antidepressant.”

“I’d like to understand why you recommend an antidepressant over hormone therapy in my case. What factors are you considering?”

These questions are collaborative, not confrontational. They demonstrate that you’ve done your research and that you want to make an informed decision together with your provider.

Finding the Right Provider

If your provider prescribes an antidepressant without discussing hormones, without asking about your cycle changes, and without considering perimenopause as a possible factor, that’s a sign of a training gap, not necessarily a bad doctor, but one who may not be equipped to address this particular issue.

Consider consulting:

  • A NAMS-certified menopause practitioner who can evaluate your symptoms in the full hormonal context
  • A provider who lists menopause or perimenopause as a clinical interest
  • A telehealth menopause clinic if local options are limited

The Bottom Line

Antidepressants are valuable medications. But when they’re prescribed as the default response to perimenopause mood symptoms without considering hormonal causes, women can end up on medications that don’t fully address what’s happening in their bodies. If your mood symptoms are new, coincide with other perimenopause symptoms, and appeared in your 40s, you deserve a conversation about hormones before accepting a prescription.

Ask the questions. Bring your data. Learn how to advocate for yourself at your next appointment. And if your provider can’t or won’t have that conversation, find one who will.